Treatment of severe refractory erythema nodosum leprosum with tumor necrosis factor inhibitor Etanercept

被引：12
|
作者：
Chowdhry, Sundeep [1 ]
Shukla, Akhilesh [1 ]
D'souza, Paschal [1 ]
Dhali, Tapan [1 ]
Jaiswal, Prashansa [1 ]
机构：
[1] ESI Postgrad Inst Med Sci & Res, Dept Dermatol Venereol & Leprol, New Delhi 110015, India
来源：
INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY | 2016年 / 5卷 / 02期
关键词：
Biologics; Etanercept; Erythema nodosum leprosum; Leprosy; Treatment;
D O I：
10.1016/j.ijmyco.2016.02.002
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Erythema nodosum leprosum (ENL) is a common complication of lepromatous leprosy. Some patients unresponsive to conventional, first-line therapeutics develop recurrent, recalcitrant ENL. Here, we report a case of severe refractory ENL that was successfully treated with Etanercept. Biologics may be considered as therapeutic alternatives in management of severe, recalcitrant ENL. (C) 2016 Asian-African Society for Mycobacteriology. Production and hosting by Elsevier Ltd. All rights reserved.
引用
收藏
页码：223 / 225
页数：3
相关论文
共 50 条
  • [41] Etanercept-Induced Pneumonitis: Severe Complication of Tumor Necrosis Factor-Alpha Blocker Treatment
    Watad, Abdulla
    Perelman, Marina
    Mansour, Ribhi
    Shoenfeld, Yehuda
    Amital, Howard
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2015, 17 (02): : 130 - 132
  • [42] A Retrospective Study of the Severe and Uncommon Variants of Erythema Nodosum Leprosum at a Tertiary Health Center in Central India
    Wankhade, Vaishali H.
    Debnath, Pritica
    Singh, Rajesh Pratap
    Sawatkar, Gitesh
    Bhat, Dharitri Mukund
    INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2019, 8 (01) : 29 - 34
  • [43] Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide
    Feuth, M.
    Brandsma, J. Wim
    Faber, W. R.
    Bhattarai, B.
    Feuth, T.
    Anderson, A. M.
    LEPROSY REVIEW, 2008, 79 (03) : 254 - 269
  • [44] TREATMENT OF CHRONIC ERYTHEMA-NODOSUM LEPROSUM WITH CYCLOSPORINE-A PRODUCES CLINICAL AND IMMUNOHISTOLOGIC REMISSION
    MILLER, RA
    SHEN, JY
    REA, TH
    HARNISCH, JP
    INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES, 1987, 55 (03) : 441 - 449
  • [45] Refractory idiopathic thrombocytopenic purpura treated with the soluble tumor necrosis factor receptor etanercept
    Litton, Gregory
    AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (04) : 344 - 344
  • [46] Treatment of recalcitrant cicatricial pemphigoid with the tumor necrosis factor α antagonist etanercept
    Sacher, C
    Rubbert, A
    König, C
    Scharffetter-Kochanek, K
    Krieg, T
    Hunzelmann, N
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (01) : 113 - 115
  • [47] Treatment of recalcitrant pemphigus vulgaris with the tumor necrosis factor α antagonist etanercept
    Berookhim, B
    Fischer, HD
    Weinberg, JM
    CUTIS, 2004, 74 (04): : 245 - 247
  • [48] Etanercept: A novel tumor necrosis factor antagonist for the treatment of psoriatic disease
    Papp, Kim A.
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2007, 11 : S1 - S2
  • [49] Comparative efficacy of thalidomide and prednisolone in the treatment of moderate to severe erythema nodosum leprosum: A randomized study (vol 50, pg 181, 2009)
    Kaur, I
    Dogra, S.
    Narang, T.
    De, D.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2009, 50 (04) : 307 - 307
  • [50] Effective management of severe chronic erythema nodosum leprosum in adolescent patient using ustekinumab and apremilast: A case report
    Mengeot, Laura
    Jachiet, Marie
    Bourrat, Emmanuelle
    Mahe, Antoine
    Cambau, Emmanuelle
    Bernard, Elise
    Pasqualini, Cassandre
    Chamouine, Abdourahim
    Truong, Jeanne
    Dumaine, Cecile
    Bertolotti, Antoine
    Franco, Justine
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (03) : e244 - e246
12345